Category:NMPA approved drugs

From HemOnc.org - A Hematology Oncology Wiki

Revision as of 12:08, 22 April 2022 by Jwarner (talk | contribs) (Jwarner moved page Category:CFDA approved drugs to Category:NMPA approved drugs: agency renamed)

(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Jump to navigation Jump to search

Drugs approved by the National Medical Products Administration (NMPA) of China, formerly known as the Chinese Food & Drug Administration (CFDA)

Subcategories

This category has the following 8 subcategories, out of 8 total.

N

Pages in category "NMPA approved drugs"

The following 9 pages are in this category, out of 9 total.

A

C

Chidamide (Epidaza)

D

Durvalumab (Imfinzi)

E

Envafolimab (Enweida)

N

P

Pembrolizumab (Keytruda)

Retrieved from "https://hemonc.org/w/index.php?title=Category:NMPA_approved_drugs&oldid=55649"

Approved drugs